 |
Prevalence (%) of clinical parameters based on data from 1 references describing 10 individuals
Add new symptom/sign to this disease
List of symptoms
Symptom/sign |
Organ system |
Percent affected |
Pubmed id |
Added on(yyyy-mm-dd) |
Edit/add reference |
Seizures |
nervous |
100 % |
25672921 |
2017-03-03 |
|
Developmental delay |
nervous |
90 % |
25672921 |
2017-03-03 |
|
Aggressive outbursts |
nervous |
80 % |
25672921 |
2017-03-03 |
|
Mental retardation |
nervous |
70 % |
25672921 |
2017-03-03 |
|
Cerebral atrophy |
nervous |
43 % |
25672921 |
2017-03-03 |
|
Cerebellar atrophy |
nervous |
43 % |
25672921 |
2017-03-03 |
|
Autism |
nervous |
40 % |
25672921 |
2017-03-03 |
|
Short stature |
multi |
40 % |
25672921 |
2017-03-03 |
|
Ataxia |
nervous |
40 % |
25672921 |
2017-03-03 |
|
Psychiatric symptom |
nervous |
10 % |
25672921 |
2017-03-03 |
|
List of references:
CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures. Rhys H Thomas, Lin Mei Zhang, Gemma L Carvill, John S Archer, Sinéad B Heavin, Simone A Mandelstam, Dana Craiu, Samuel F Berkovic, Deepak S Gill, Heather C Mefford, Ingrid E Scheffer, ,
Neurology - Mar 2015
|